Want to see HK:1112 full AI Analyst Report?
1112 Stock Chart & Stats
HK$18.44
-HK$0.20(-1.37%)
At close: 4:00 PM EDT
HK$18.44
-HK$0.20(-1.37%)
Day’s Range― - ―
52-Week RangeHK$10.10 - HK$18.96
Previous CloseN/A
Volume1.46M
Average Volume (3M)2.06M
Market Cap
HK$12.07B
Enterprise ValueHK$13.15K
Total Cash (Recent Filing)HK$1.99B
Total Debt (Recent Filing)HK$7.72B
Price to Earnings (P/E)13.9
Beta0.80
Next Earnings
Mar 23, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.91%
Share Statistics
EPS (TTM)1.13
Shares Outstanding645,561,340
10 Day Avg. Volume3,513,003
30 Day Avg. Volume2,064,922
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)1.26
Price to Sales (P/S)0.53
P/FCF Ratio7.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$23.71Price Target Upside28.56% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)1.54
Revenue Forecast (FY)HK$16.86B
Bulls Say, Bears Say
Bulls Say
Strong Gross MarginsSustained gross margins of roughly 60–64% indicate attractive unit economics in the branded nutrition portfolio. This provides room to absorb channel, marketing, and input-cost pressure while supporting ongoing product investment.
Positive Free Cash FlowConsistently positive free cash flow, with 2025 generation closely tracking earnings, demonstrates that reported profits convert into cash. This supports reinvestment, working-capital needs, and eventual balance-sheet strengthening.
Revenue GrowthThe reported revenue-growth rate indicates meaningful demand and distribution momentum for the company’s branded health and nutrition products. Sustained sales expansion can improve operating leverage and strengthen market position across consumer channels.
Bears Say
Volatile ProfitabilityA loss followed by only a thin net-margin recovery shows that strong gross economics have not consistently translated into bottom-line earnings. Persistent cost, pricing, or product-mix pressure could limit reinvestment and shareholder returns.
Elevated LeveragePersistent leverage reduces financial flexibility and increases sensitivity to uneven earnings. With equity not consistently compounding, the company may have less capacity to absorb setbacks or accelerate investment without relying on additional borrowing.
Weaker Cash Flow MomentumAlthough cash flow remains positive, its decline and modest coverage relative to debt indicate that deleveraging may be gradual. Reduced cash momentum could constrain marketing, product development, and the company’s ability to withstand operating volatility.
Health and Happiness (H&H) International Holdings News
1112 FAQ
What was Health and Happiness (H&H) International Holdings Limited’s price range in the past 12 months?
Health and Happiness (H&H) International Holdings Limited lowest stock price was HK$10.10 and its highest was HK$18.96 in the past 12 months.
What is Health and Happiness (H&H) International Holdings Limited’s market cap?
Health and Happiness (H&H) International Holdings Limited’s market cap is HK$12.07B.
When is Health and Happiness (H&H) International Holdings Limited’s upcoming earnings report date?
Health and Happiness (H&H) International Holdings Limited’s upcoming earnings report date is Mar 23, 2027 which is in 200 days.
How were Health and Happiness (H&H) International Holdings Limited’s earnings last quarter?
Health and Happiness (H&H) International Holdings Limited released its earnings results on Aug 25, 2026. The company reported HK$1.671 earnings per share for the quarter.
Is Health and Happiness (H&H) International Holdings Limited overvalued?
According to Wall Street analysts Health and Happiness (H&H) International Holdings Limited’s price is currently Undervalued.
Does Health and Happiness (H&H) International Holdings Limited pay dividends?
Health and Happiness (H&H) International Holdings Limited pays a Semiannually dividend of HK$0.82 which represents an annual dividend yield of 1.91%. See more information on Health and Happiness (H&H) International Holdings Limited dividends here
What is Health and Happiness (H&H) International Holdings Limited’s EPS estimate?
Health and Happiness (H&H) International Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Health and Happiness (H&H) International Holdings Limited have?
Health and Happiness (H&H) International Holdings Limited has 645,561,340 shares outstanding.
What happened to Health and Happiness (H&H) International Holdings Limited’s price movement after its last earnings report?
Health and Happiness (H&H) International Holdings Limited reported an EPS of HK$1.671 in its last earnings report. Following the earnings report the stock price went down -0.269%.
Which hedge fund is a major shareholder of Health and Happiness (H&H) International Holdings Limited?
Currently, no hedge funds are holding shares in HK:1112
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Health and Happiness (H&H) International Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
HK$23.71 (28.56% Upside)
HK$23.71 (28.56% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-14.54%
12-Months-Change
Fundamentals
Return on Equity
1.91%
Trailing 12-Months
Asset Growth
6.09%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Health and Happiness (H&H) International Holdings Limited
As an investment holding entity, Health and Happiness (H&H) International Holdings Limited specializes in the global production and distribution of nutritional and care products designed for families and infants. Its offerings are categorized into several key segments. The Infant Formulas division crafts nutritional formulas for children up to age seven, alongside specialized milk products for pregnant and breastfeeding women. The Probiotic Supplements division provides various forms of probiotics, including sachets, capsules, and tablets, catering to the needs of babies, children, and expecting mothers. Within its Adult Nutrition and Care Products segment, H&H develops and markets a range of items such as vitamins, general health supplements, skincare solutions, and sports nutrition for grown-ups. Complementing its infant offerings, the Other Pediatric Products segment focuses on manufacturing dried baby foods, additional nutritional supplements, and general baby care items. Furthermore, its Pet Nutrition and Care segment creates pet food, health-enhancing supplements, and bone broth products for animals. Beyond these core product lines, the company's activities extend to research, development, and processing of diverse ingredients like meat, fruit, and vegetable powders, as well as candies. It actively researches, develops, manufactures, and sells specialized nutritional foods, manages the marketing and distribution of organic baby foods, and handles the wholesale, retail, import, and export of infant nutritional and personal care products. H&H also engages in the trading and sale of adult vitamins, health supplements, probiotic skincare, and sports nutrition items, while offering online sales platforms, software and IT solutions, and packaging services. Its extensive product portfolio is marketed under well-known brands such as Biostime, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, Good Gout, Aurelia London, and CBII. Established in 1999, the company adopted its current name, Health and Happiness (H&H) International Holdings Limited, in June 2017, having previously operated as Biostime International Holdings Limited. Headquartered in Quarry Bay, Hong Kong, H&H functions as a subsidiary of Biostime Pharmaceuticals (China) Limited.
Health and Happiness (H&H) International Holdings (1112) Earnings & Revenues
1112 Company Deck
1112 Earnings Call
Q2 2026
0:00 / 0:00
1112 Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
HK$23.71
▲(28.56% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Want Want China Holdings
―
China Mengniu Dairy Co
―
Vitasoy International Holdings
―
Ausnutria Dairy Corp. Ltd.
―
China Feihe Limited
―





